e 4031 and crizotinib

e 4031 has been researched along with crizotinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, K; Choi, S; Hong, S; Hong, SS; Jung, HY; Jung, KH; Lee, JC; Mah, S; Park, JH; Rho, JK; Tae, HS	1

Other Studies

1 other study(ies) available for e 4031 and crizotinib

Article	Year
Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design. Journal of medicinal chemistry, 2017, 11-22, Volume: 60, Issue:22 Topics: Amino Acid Substitution; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Crizotinib; Drug Design; Drug Resistance, Neoplasm; ERG1 Potassium Channel; Humans; Kinetics; Piperidines; Pyrazoles; Pyridines; Pyrimidines; Quinolines; Rats; Receptor Protein-Tyrosine Kinases; Signal Transduction; Structure-Activity Relationship; Sulfones	2017

Article

Year

Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design.

Journal of medicinal chemistry, 2017, 11-22, Volume: 60, Issue:22

Topics: Amino Acid Substitution; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Crizotinib; Drug Design; Drug Resistance, Neoplasm; ERG1 Potassium Channel; Humans; Kinetics; Piperidines; Pyrazoles; Pyridines; Pyrimidines; Quinolines; Rats; Receptor Protein-Tyrosine Kinases; Signal Transduction; Structure-Activity Relationship; Sulfones

2017